Genmab after Merus acquisition Genmab strengthens position among global immunotherapy leaders with Merus acquisition From a patent perspective, the acquisition represents a highly strategic move. Genmab now advances to position 25 among the leading immunotherapy companies, measured by the number of world-class patents. This transaction further strengthens [...]